Industry News

DSM Claims its VitroStealth® Coating to be Fit for Use in Biosensors for Glucose Monitoring

Published on 2011-10-31. Author : SpecialChem

DSM, one of the global leaders in biomedical materials, announced that new test results indicate its VitroStealth® coating can be used in the design of biosensors, such as those for continuous glucose monitoring. VitroStealth® coating is a durable and non-fouling coating designed to prevent unwanted protein absorption and cellular adhesion on synthetic surfaces. Study data indicates that VitroStealth® coating does not inhibit the transport of glucose or oxygen through coated filters. This opens the door to its application in the design of biosensors, where permeability and non-fouling are important requirements.

With these characteristics, VitroStealth® coating is expected to improve the performance of long-term, in-vivo diagnostic devices like biosensors. For example, VitroStealth® coating is designed to prevent protein adhesion, thereby increasing the longevity of biosensors and extending the time of accurate signal transmission. The device can remain in the patient for a longer period of time, which improves cost efficiency. VitroStealth® coating's characteristics also indicate its application in the design of in-vitro diagnostics, such as point-of-care capillaries, blood capillaries and microfluidic devices, and ex-vivo tools, such as blood filters and pre-filled syringes.

"As DSM continues to break new ground in biomedical materials and technology we are excited to expand VitroStealth® coating further in the medical diagnostic arena though collaborative relationships with innovative companies," said John Marugg, Business Manager, Coatings, DSM Biomedical. "The advanced VitroStealth® coating technology has the potential to be used in an expanding array of applications that can ultimately help manage or improve the health of patients."

About DSM Biomedical

As patient healthcare needs continue to evolve at a rapid pace, so must the response by the medical community. Trends such as an aging population, increasing cases of obesity, and patient requests for continued comfort and convenience have led to a demand for new and improved treatments using innovative medical devices and drug delivery systems. DSM Biomedical is uniquely positioned to supply materials that help design and deliver products and technologies with clear competitive advantages, resulting in improved performance.

Source: DSM

Sustainnovation is not a buzzword
Channel Alerts

Receive weekly digests on hot topics

Back to Top